Allograft survival enhancement using doxycycline in alkali-burned mouse corneas

Acta Ophthalmologica

Volumn 91, Issue 5, 2013, Pages

  Ling, Shiqi ^a   Li, Weihua ^b   Liu, Lin ^c   Zhou, Hongmei ^d   Wang, Tao ^a   Ye, Hui ^a   Liang, Lingyi ^b   Yuan, Jin ^b  

^a SUN YAT SEN UNIVERSITY   (China)

^b SUN YAT SEN UNIVERSITY   (China)

^c GUANGZHOU GENERAL HOSPITAL OF GUANGZHOU MILITARY COMMAND   (China)

^d Guangzhou Children's Hospital   (China)

Author keywords

allograft; cornea; doxycycline; interleukin 1 ; vascular endothelial growth factor A

Indexed keywords

DOXYCYCLINE; INTERLEUKIN 1BETA; MESSENGER RNA; SODIUM HYDROXIDE; VASCULOTROPIN; VASCULOTROPIN A;

ALLOTRANSPLANTATION; ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CAUSTIC BURN; CONTROLLED STUDY; CORNEA INJURY; CORNEA TRANSPLANTATION; ENZYME LINKED IMMUNOSORBENT ASSAY; GRAFT REJECTION; GRAFT SURVIVAL; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; ISOGRAFT; KERATITIS; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; SCORING SYSTEM; SLIT LAMP; SURVIVAL TIME; WHOLE MOUNT IMMUNOFLUORESCENCE;

ALLOGRAFT; CORNEA; DOXYCYCLINE; INTERLEUKIN-1Β; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

ALKALIES; ANIMALS; ANTI-BACTERIAL AGENTS; BURNS, CHEMICAL; CORNEA; CORNEAL NEOVASCULARIZATION; CORNEAL TRANSPLANTATION; DISEASE MODELS, ANIMAL; DOXYCYCLINE; ENZYME-LINKED IMMUNOSORBENT ASSAY; EYE BURNS; GENE EXPRESSION REGULATION; GRAFT REJECTION; GRAFT SURVIVAL; IMMUNOHISTOCHEMISTRY; INTERLEUKIN-1BETA; MALE; MICE; MICE, INBRED BALB C; MICROSCOPY, ELECTRON, TRANSMISSION; OPHTHALMIC SOLUTIONS; REAL-TIME POLYMERASE CHAIN REACTION; RNA; TRANSPLANTATION, HOMOLOGOUS; TREATMENT OUTCOME; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84880322795     PISSN: 1755375X     EISSN: 17553768     Source Type: Journal    
DOI: 10.1111/aos.12070     Document Type: Article

References (46)

1. Akpek EK, Merchant A, Pinar V, &, Foster CS, (1997): Ocular rosacea: patient characteristics and follow-up. Ophthalmology 104: 1863-1867.
2. Amescua G, Collings F, Sidani A, et al., (2008): Effect of CXCL-1/KC production in high risk vascularized corneal allografts on T cell recruitment and graft rejection. Transplantation 85: 615-625.
3. Amin AR, Attur MG, Thakker GD, Patel PD, Vyas PR, Patel RN, Patel IR, &, Abramson SB, (1996): A novel mechanism of action of tetracyclines: effects on nitric oxide synthases. Proc Natl Acad Sci USA 93: 14014-14019.
4. Asai T, Choi BK, Kwon PM, Kim WY, Kim JD, Vinay DS, Gebhardt BM, &, Kwon BS, (2007): Blockade of the 4-1BB (CD137)/4-1BBL and/or CD28/CD80/CD86 costimulatory pathways promotes corneal allograft survival in mice. Immunology 121: 349-358.
5. Aydin E, Kivilcim M, Peyman GA, Esfahani MR, Kazi AA, &, Sanders DR, (2008): Inhibition of experimental angiogenesis of cornea by various doses of doxycycline and combination of triamcinolone acetonide with low-molecular-weight heparin and doxycycline. Cornea 27: 446-453.
6. Bayne K, (1996): Revised Guide for the Care and Use of Laboratory Animals available. American Physiological Society. The Physiologist 39: 199, 208-211.
7. Cao Y, &, Liu Q, (2007): Therapeutic targets of multiple angiogenic factors for the treatment of cancer and metastasis. Adv Cancer Res 97: 203-224. Review.
8. Constad WH, &, Taraschanskiy K, (2001): Immunology of corneal transplantation. Clin Rev Allergy Immunol 20: 215-241.
9. Coster DJ, &, Williams KA, (2003): Management of high-risk corneal grafts. Eye (Lond) 17: 996-1002. Review.
10. Culbertson WW, Huang AJ, Mandelbaum SH, Pflugfelder SC, Boozalis GT, &, Miller D, (1993): Effective treatment of phlyctenular keratoconjunctivitis with oral tetracycline. Ophthalmology 100: 1358-1366.
11. Cursiefen C, (2007): Immune privilege and angiogenic privilege of the cornea. Chem Immunol Allergy 92: 50-57. Review.
12. Cursiefen C, Martus P, Nguyen NX, Langenbucher A, Seitz B, &, Kuchle M, (2002): Corneal neovascularization after nonmechanical versus mechanical corneal trephination for non-high-risk keratoplasty. Cornea 21: 648-652.
13. D'Amato RJ, Loughnan MS, Flynn E, &, Folkman J, (1994): Thalidomide is an inhibitor of angiogenesis. Proc Natl Acad Sci USA 91: 4082-4085.
14. Dan L, Shi-long Y, Miao-li L, Yong-ping L, Hong-jie M, Ying Z, &, Xiang-gui W, (2008): Inhibitory effect of oral doxycycline on neovascularization in a rat corneal alkali burn model of angiogenesis. Curr Eye Res 33: 653-660.
15. Dana MR, &, Streilein JW, (1996): Loss and restoration of immune privilege in eyes with corneal neovascularization. Invest Ophthalmol Vis Sci 37: 2485-2494.
16. Dursun D, Kim MC, Solomon A, &, Pflugfelder SC, (2001): Treatment of recalcitrant recurrent corneal epithelial erosions with inhibitors of matrix metalloproteinases-9, doxycycline and corticosteroids. Am J Ophthalmol 132: 8-13.
17. Feng C, Chen J, &, Li Y, (1994): Factors of graft failure after chemical corneal injury. Chin J Ophthalmol 30: 277-279.
18. Frucht-Pery J, Sagi E, Hemo I, &, Ever-Hadani P, (1993): Efficacy of doxycycline and tetracycline in ocular rosacea. Am J Ophthalmol 116: 88-92.
19. Hanemaaijer R, Sorsa T, Konttinen YT, et al., (1997): Matrix metalloproteinase-8 is expressed in rheumatoid synovial fibroblasts and endothelial cells. Regulation by tumor necrosis factor-alpha and doxycycline. J Biol Chem 272: 31504-31509.
20. Holland EJ, Olsen TW, Sterrer J, Ketchum JM, Mindrup EA, &, Gruber SA, (1994): Suppression of graft rejection using 15-deoxysperguallin in the penetrating keratoplasty model. Cornea 13: 28.
21. Hope-Ross MW, Chell PB, Kervick GN, McDonnell PJ, &, Jones HS, (1994): Oral tetracycline in the treatment of recurrent corneal erosions. Eye 8: 384-388.
22. King WJ, Comer RM, Hudde T, Larkin DF, &, George AJ, (2000): Cytokine and chemokine expression kinetics after corneal transplantation. Transplantation 70: 1225-1233.
23. Küchle M, Cursiefen C, Nguyen NX, Langenbucher A, Seitz B, Wenkel H, Martus P, &, Naumann GO, (2002): Risk factors for corneal allograft rejection: intermediate results of a prospective normal-risk keratoplasty study. Graefes Arch Clin Exp Ophthalmol 240: 580-584.
24. Laria C, Alio JL, &, Ruiz-Moreno JM, (1997): Combined non-steroidal therapy in experimental corneal injury. Ophthalmic Res 29: 145-153.
25. Li D-Q, Lokeshwar BL, Solomon A, Monroy D, Ji Z, &, Pflugfelder SC, (2001): Regulation of MMP-9 production by human corneal epithelial cells. Exp Eye Res 73: 449-459.
26. Ling S, Qi C, Li W, Xu J, &, Kuang W, (2009a): Crucial role of corneal lymphangiogenesis for allograft rejection in alkali-burned cornea bed. Clin Exp Ophthalmol 37: 874-883.
27. Ling S, Lin H, Liang L, Xu J, Xu C, Zhao W, &, Liu Z, (2009b): Development of new lymphatic vessels in alkali-burned corneas. Acta Ophthalmol 87: 315-322.
28. Ling SQ, Li WH, Xu JG, Kuang WH, &, Li CY, (2010): The relationship between corneal lymphangiogenesis and inflammation index after corneal alkali injury. Zhonghua Yan Ke Za Zhi 4611: 1000-1005.
29. Ma DH, Chen JK, Kim WS, Hao YX, Wu HC, Tsai RJ, Hwang DG, &, Zhang F, (2001): Expression of matrix metalloproteinases 2 and 9 and tissue inhibitors of metalloproteinase 1 and 2 in inflammation-induced corneal neovascularization. Ophthalmic Res 33: 353-362.
30. Maguire MG, Stark WJ, Gottsch JD, Stulting RD, Sugar A, Fink NE, &, Schwartz A, (1994): Risk factors for corneal graft failure and rejection in the collaborative corneal transplantation studies. Collaborative Corneal Transplantation Studies Research Group. Ophthalmology 101: 1536-1547.
31. Qazi Y, Maddula S, &, Ambati BK, (2009): Mediators of ocular angiogenesis. J Genet 88: 495-515. Review.
32. Reim M, Redbrake C, &, Schrage N, (2001): Chemical and thermal injuries of the eyes. Surgical and medical treatment based on clinical and pathophysiological findings. Arch Soc Esp Oftalmol 76: 79-124.
33. Samolov B, Steen B, Seregard S, van der Ploeg I, Montan P, &, Kvanta A, (2005): Delayed inflammation-associated corneal neovascularization in MMP-2-deficient mice. Exp Eye Res 80: 159-166.
34. Sano Y, Ksander BR, &, Streilein JW, (1995): Fate of orthotopic corneal allografts in eyes that cannot support anterior chamber-associated immune deviation induction. Invest Ophthalmol Vis Sci 36: 2176-2185.
35. Shlopov BV, Smith GN Jr, Cole AA, &, Hasty KA, (1999): Differential patterns of response to doxycycline and transforming growth factor beta1 in the down-regulation of collagenases in osteoarthritic and normal human chondrocytes. Arthritis Rheum 42: 719-727.
36. Singh N, Jani PD, Suthar T, Amin S, &, Ambati BK, (2006): Flt-1 intraceptor induces the unfolded protein response, apoptotic factors, and regression of murine injury-induced corneal neovascularization. Invest Ophthalmol Vis Sci 47: 4787-4793.
37. Sipos EP, Tamargo RJ, Weingart JD, &, Brem H, (1994): Inhibition of tumor angiogenesis. Ann N Y Acad Sci 732: 263-272.
38. Sobrin L, Selzer MG, Lokeshwar BL, et al., (2000): Stromelysin (MMP-3) activates pro-MMP-9 secreted by corneal epithelial cells. Invest Ophthalmol Vis Sci 41: 1703-1709.
39. Solomon A, Rosenblatt M, Li DQ, Liu Z, Monroy D, Ji Z, Lokeshwar BL, &, Pflugfelder SC, (2000): Doxycycline inhibition of interleukin-1 in the corneal epithelium. Invest Ophthalmol Vis Sci 41: 2544-2557.
40. Streilein JW, Yamada J, Dana MR, &, Ksander BR, (1999): Anterior chamber-associated immune deviation, ocular immune privilege, and orthotopic corneal allografts. Transplant Proc 31: 1472-1475. Review.
41. Stuart PM, Pan F, Yin X, Haskova Z, Plambeck S, &, Ferguson TA, (2004): Effect of metalloprotease inhibitors on corneal allograft survival. Invest Ophthalmol Vis Sci 45: 1169-1173.
42. Wagoner MD, (1997): Chemical injuries of the eye: current concepts in pathophysiology and therapy. Surv Ophthalmol 41: 275-313. Review.
43. Williams KA, &, Coster DJ, (2007): The immunobiology of corneal transplantation. Transplantation 84: 806-813. Review.
44. Zengin N, Tol H, Gunduz K, Okudan S, Balevi S, &, Endogru H, (1995): Meibomian gland dysfunction and tear film abnormalities in rosacea. Cornea 14: 144-146.
45. Zhang W, Pan Z, &, Zhai C, (2001): Efficacy of topical cyclosporine A on keratoplasty rejection in rats. Zhonghua Yan Ke Za Zhi 37: 140-143.
46. Zheng X, Feng K, Li B, Yang JZ, &, Ge JJ, (2004): Effect of lamellar keratoplasty time on the production of serum specific antibody in corneal alkali burns. Chin J Ophthalmol 40: 160-164.